GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicine Man Technologies Inc (OTCPK:SHWZ) » Definitions » Beneish M-Score

Medicine Man Technologies (Medicine Man Technologies) Beneish M-Score : -3.28 (As of May. 12, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Medicine Man Technologies Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.28 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medicine Man Technologies's Beneish M-Score or its related term are showing as below:

SHWZ' s Beneish M-Score Range Over the Past 10 Years
Min: -14.17   Med: -2.59   Max: 62.07
Current: -3.28

During the past 10 years, the highest Beneish M-Score of Medicine Man Technologies was 62.07. The lowest was -14.17. And the median was -2.59.


Medicine Man Technologies Beneish M-Score Historical Data

The historical data trend for Medicine Man Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicine Man Technologies Beneish M-Score Chart

Medicine Man Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.39 -2.56 -0.33 -2.61 -3.28

Medicine Man Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -2.74 -3.13 -3.13 -3.28

Competitive Comparison of Medicine Man Technologies's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Medicine Man Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicine Man Technologies's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicine Man Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medicine Man Technologies's Beneish M-Score falls into.



Medicine Man Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medicine Man Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8783+0.528 * 1.1427+0.404 * 1.0472+0.892 * 1.082+0.115 * 0.7853
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1032+4.679 * -0.164518-0.327 * 1.1321
=-3.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $4.3 Mil.
Revenue was 43.325 + 46.747 + 42.375 + 40.001 = $172.4 Mil.
Gross Profit was 7.034 + 21.438 + 24.519 + 23.033 = $76.0 Mil.
Total Current Assets was $53.7 Mil.
Total Assets was $358.1 Mil.
Property, Plant and Equipment(Net PPE) was $65.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $20.9 Mil.
Selling, General, & Admin. Expense(SGA) was $70.9 Mil.
Total Current Liabilities was $55.5 Mil.
Long-Term Debt & Capital Lease Obligation was $183.4 Mil.
Net Income was -29.365 + -0.322 + -6.608 + 1.745 = $-34.6 Mil.
Non Operating Income was -2.318 + 4.516 + 1.468 + 8.504 = $12.2 Mil.
Cash Flow from Operations was 3.452 + 6.946 + 2.683 + -0.88 = $12.2 Mil.
Total Receivables was $4.5 Mil.
Revenue was 40.147 + 43.191 + 44.263 + 31.778 = $159.4 Mil.
Gross Profit was 21.719 + 22.476 + 25.156 + 10.938 = $80.3 Mil.
Total Current Assets was $71.7 Mil.
Total Assets was $322.9 Mil.
Property, Plant and Equipment(Net PPE) was $45.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $10.7 Mil.
Selling, General, & Admin. Expense(SGA) was $59.4 Mil.
Total Current Liabilities was $47.4 Mil.
Long-Term Debt & Capital Lease Obligation was $142.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4.261 / 172.448) / (4.484 / 159.379)
=0.024709 / 0.028134
=0.8783

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(80.289 / 159.379) / (76.024 / 172.448)
=0.503761 / 0.440852
=1.1427

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (53.668 + 65.347) / 358.144) / (1 - (71.735 + 45.288) / 322.883)
=0.66769 / 0.637568
=1.0472

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=172.448 / 159.379
=1.082

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(10.66 / (10.66 + 45.288)) / (20.933 / (20.933 + 65.347))
=0.190534 / 0.242617
=0.7853

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(70.933 / 172.448) / (59.422 / 159.379)
=0.41133 / 0.372835
=1.1032

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((183.396 + 55.457) / 358.144) / ((142.836 + 47.381) / 322.883)
=0.666919 / 0.589121
=1.1321

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-34.55 - 12.17 - 12.201) / 358.144
=-0.164518

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medicine Man Technologies has a M-score of -3.28 suggests that the company is unlikely to be a manipulator.


Medicine Man Technologies Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicine Man Technologies (Medicine Man Technologies) Business Description

Traded in Other Exchanges
Address
4880 Havana Street, Suite 201, Denver, CO, USA, 80239
Medicine Man Technologies Inc is engaged in providing general consulting services in the cannabis industry. The company also provide seminar which includes giving guidance and tips on industry opportunities, medical and recreational market trends, cultivation methodologies and technology, extraction technology, dispensary operation, security requirements. The company's operating segment includes- Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products; Other, consisting of all other income and expenses. It generates maximum revenue from the Retail segment. The company is now operating under its new trade name, Schwazze.
Executives
Christine Jones officer: Chief Legal Officer C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Forrest Hoffmaster officer: CFO C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Nirup Krishnamurthy director, officer: President 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Kathy P Vrabeck director 625 WESTPORT PARKWAY, GRAPEVINE TX 76051
Jeff Garwood director 55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915
Pratap Chandra Mukharji director 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Salim Husan Wahdan director 4880 HAVANA ST., STE. 201, DENVER CO 80239
Paul Joseph Montalbano director 4880 HAVANA ST., STE. 201, DENVER CO 80239
Brad Stewart director C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017
Justin Dye director, 10 percent owner, officer: CEO C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Jeffrey Alley Cozad director, 10 percent owner C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Crw Capital Holdings Ii, Llc 10 percent owner 4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209
Crw Capital, Llc 10 percent owner 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Crw Capital Cann Holdings, Llc 10 percent owner 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Brian Ruden 10 percent owner C/O 4880 HAVANA STREET, SUITE 102, DENVER CO 80239